There's only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.
Private-equity firm Carlyle Group is in talks to buy Baxter International's spinoff kidney business, Vantive, The Wall Street Journal reports. The sale of the business could go for more than $4 ...